Skip to main content
Sopharma AD logo

Sopharma AD — Investor Relations & Filings

Ticker · SFA ISIN · BG11SOSOBT18 LEI · 097900BGGW0000048796 BSOBGN Manufacturing
Open in API
Filings indexed 1,481 across all filing types
Latest filing 2023-12-12 Director's Dealing
Country BG Bulgaria
Listing BSOBGN SFA

About Sopharma AD

https://www.sopharmagroup.com/

Sopharma AD is a pharmaceutical company founded in 1933 that specializes in the production, distribution, and export of a wide range of medical products. The company's portfolio includes prescription (Rx) and over-the-counter (OTC) medicines, encompassing both branded and generic drugs. A key area of focus is its traditional plant-based products. Sopharma develops treatments for various conditions, including liver disease, pain management, and smoking cessation. Operating from EU-GMP certified facilities, the company also provides contract manufacturing services and has an established presence in over 40 international markets.

Recent filings

Filing Released Lang Actions
Notification from "Donev investments holding" AD under Art. 19 of Regulation (EU) No 596/2014 of 8 December 2023.
Director's Dealing Classification · 100% confidence The document text explicitly contains the heading "NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014". It details transactions made by a 'person discharging managerial responsibilities' (Ognian Donev) and a 'person closely associated' (Donev Investments Holding AD) concerning shares/warrants of Sopharma AD. This structure and content are characteristic of mandatory regulatory filings reporting insider trading activities, which fall under the category of Director's Dealing (DIRS) as per the provided definitions, specifically covering personal share transactions by directors and executives.
2023-12-12 English
Notification from "Donev investments holding" AD under Art. 19 of Regulation (EU) No 596/2014 of 8 December 2023.
Director's Dealing Classification · 100% confidence The document text details transactions involving 'Shares' by a 'person closely associated' with management ('Donev Investments Holding AD' and 'Ognian Donev') concerning the issuer 'Sopharma AD'. Specifically, it lists the 'Nature of the transaction' as 'Buy' along with corresponding 'Price(s) and volume(s)'. This structure is characteristic of mandatory regulatory filings reporting insider trading or director/related party transactions, which corresponds to the Director's Dealing category.
2023-12-12 English
Notification from "Donev investments holding" AD under Art. 19 of Regulation (EU) No 596/2014 of 7 December 2023.
Director's Dealing Classification · 100% confidence The document text explicitly contains the title "NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014". It details transactions made by a 'person discharging managerial responsibilities' (Ognian Donev) and a 'person closely associated' (Donev Investments Holding AD) concerning shares/warrants of Sopharma AD. This content directly corresponds to the definition of Director's Dealing (insider trades) as per the provided schema, which is classified as code DIRS.
2023-12-11 English
Notification from "Donev investments holding" AD under Art. 19 of Regulation (EU) No 596/2014 of 7 December 2023.
Director's Dealing Classification · 100% confidence The document text consists of structured tables detailing a transaction involving a person discharging managerial responsibilities ('Donev Investments Holding AD') and the issuer ('Sopharma AD'). Specifically, it details the 'Nature of the transaction' as 'Buy' for 'Shares' and lists the 'Price(s)' and 'volume(s)'. This format is characteristic of mandatory regulatory filings reporting insider transactions, which falls under the category of Director's Dealing (DIRS) as per the provided definitions, which cover 'Report of personal share transactions by company directors and executives (insider trades)'.
2023-12-11 English
Notification for buy-back of treasury sahres
Transaction in Own Shares Classification · 100% confidence The document is titled 'NOTIFICATION according to Art. 111 para. 6 of the LPA for repurchase of shares' and explicitly states that 'Sopharma' AD notifies that the company intends to buy back treasury shares. It details the number of shares, the buy-back price, and the purchase date. This directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase). The filing type code for this activity is POS.
2023-12-11 English
Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 6 December 2023.
Regulatory Filings Classification · 19% confidence
2023-12-11 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.